Independent education resourceInformation here does not replace care from a qualified health professional.
Peptide Therapy GuideClear peptide education

Educational guide

Syn-AKE and Cell Regeneration - Biotech Peptides

Syn-AKE and Cell Regeneration by Dr. Usman | May 6, 2022 | Research What Is Syn-AKE Peptide? The Syn-AKE peptide is a synthetic analog of the protein Waglerin-1. It is a 21 amino acid protein isolated from tropidolaemus wagleri. However, Syn-AKE includes only

Written by Peptide Therapy Guide Editorial Team
For education only

This guide cannot diagnose a condition or recommend a personal treatment plan. Discuss medical questions with a qualified professional.

Syn-AKE and Cell Regeneration

by Dr. Usman | May 6, 2022 | Research

What Is Syn-AKE Peptide?

The Syn-AKE peptide is a synthetic analog of the protein Waglerin-1. It is a 21 amino acid protein isolated from tropidolaemus wagleri. However, Syn-AKE includes only three of the amino acids which are present in the original endogenous sequence. It represents the perceived active portion of the protein and appears to produce similar action as that of the original Waglerin-1, but researchers assert that it appears to act in a controlled way.

What Are Syn-peptides?

Syn-peptides are synthetically developed peptides similar in structure to a naturally occurring peptide. They typically appear to assume the action of the naturally occurring form. Peptides are short proteins which research posits may indeed be short enough to cross the skin barrier in certain organisms.

How Does Syn-AKE Peptide Work?

Syn-AKE peptide is designed to mimic paralytic action. The Syn-AKE peptide was developed with close structural similarities to the Waglerin-1 peptide. The Waglerin-1 peptide was proposed to induce paralysis in laboratory studies, and the synthetic peptide may potentially produce a similar effect via its chemically similar structure. Researchers believe the molecule may small enough to penetrate the skin barrier. However, only tiny quantities of the molecule has been hypothesized to be able to penetrate muscle cells beneath the skin structure.

Waglerin-1 has been proposed by various researchers to induce sodium uptake by muscle cells by interacting with the mnAchR receptor. Preventing sodium uptake may block the transmission of nerve impulses to the muscles, and the muscles remain relaxed.

Dr. Usman

Dr. Usman (BSc, MBBS, MaRCP) completed his studies in medicine at the Royal College of Physicians, London. He is an avid researcher with more than 30 publications in internationally recognized peer-reviewed journals. Dr. Usman has worked as a researcher and a medical consultant for reputable pharmaceutical companies such as Johnson & Johnson and Sanofi.

Latest Post

BPC157: Molecular Characterization, Pleiotropic Signaling Mechanisms, and Preclinical Research

Copper Peptides: Molecular Characterization, Mechanistic Biology, and Emerging Research

Modified GRF 1-29 and GHRP-2 Peptide Blend: Receptor Pharmacology, Somatotroph Signaling, and Neuroendocrine Research

Fragment 176-191, Modified GRF 1-29, and Ipamorelin Blend: Adipose Metabolism, GH Axis Modulation, and Receptor Signaling Research

PNC-27: Structural Characterization, HDM-2-Dependent Membrane Targeting, and Selective Tumor Cell Necrosis

Connected reading

Helpful context for this guide

Source-derived material selected through this article’s indexed topics.

Research context

Read sources and limitations before applying a claim.

Research Studies Involving NAD+

by Dr. Usman | Apr 4, 2022 | Research NAD+ peptide also acts as a means of communication between cells. NAD+ has been suggested to act as an extracellular signaling molecule and helps regulate pivotal physiological functions. These functions include the activity of the intestine, bladder, neurons, and blood vessels. Research into the peptide has also implicated its activity in energy conversion, immune mediation, regulation of circadian rhythm, and timely DNA repair. NAD+ is an important biomolecule, but endogenous production appears to level off and then decline over time, which signifies its importance in age-related disease research.

Source: biotechpeptides.com ↗
Practical and safety references

These excerpts are educational, not personalised medical instructions.

Potential benefits

Primary Benefits

Achieves 26-30% wrinkle reduction within 3 weeks through competitive nAChR blockade, with immediate smoothing effects visible within 24 hours of first application. 3,700-fold selectivity for the alpha-epsilon nAChR subunit interface provides highly targeted muscle-type receptor blockade without affecting neuronal nicotinic receptors. Beyond neuromuscular action, demonstrates MMP inhibition (collagen protection), SIRT1 activation (cellular longevity), and antioxidant DPPH radical scavenging.

Source: peptideinitiative.com ↗
P

About the author

Peptide Therapy Guide Editorial Team

Editorial team for Peptide Therapy Guide.

View all articles →